Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Up 34.8% in January

Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 22,100 shares, a growth of 34.8% from the January 15th total of 16,400 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Basilea Pharmaceutica Price Performance

Shares of Basilea Pharmaceutica stock remained flat at $52.83 during trading hours on Tuesday. The company has a debt-to-equity ratio of 5.70, a quick ratio of 3.27 and a current ratio of 4.10. Basilea Pharmaceutica has a twelve month low of $38.60 and a twelve month high of $52.83. The firm has a 50-day moving average price of $52.83 and a 200 day moving average price of $51.95.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.